Orthodontics artificial intelligence company DentalMonitoring has rolled out a software update following the company's De Novo approval from the FDA.
The program analyzes intraoral remote scans during orthodontic treatment to help providers detect, track and monitor progress, according to a Nov. 20 news release.
The company conducted a clinical study involving more than 2,650 patients, yielding over 13,000 clinical results. FDA-validated indications include archwire and auxiliaries passivity, bracket debonding, open self-ligating clips, tie loss, aligner seats and unseats, retainer seats and unseats, button or attachment loss, black triangles, extraction space closure, midline deviation, anterior space closure, overbite, open bite, overjet and canine class.
DentalMonitoring also launched its SmartSTL feature in the U.S., enabling orthodontists to request updated STL files through the DentalMonitoring dashboard, the release stated.
The company earned De Novo approval from the FDA in May.